Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: BRKR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on BRKR, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 20,145 BRKR shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 20,145 shares
    Change vs previous 13F -3,168 shares

    0.02% of the 13F portfolio, value $1,212,326.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 23,313 shares
    Change vs previous 13F +10,163 shares

    0.02% of the 13F portfolio, value $842,066.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 13,150 shares
    Change vs previous 13F +4,982 shares

    0.01% of the 13F portfolio, value $619,543.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 8,168 shares
    Change vs previous 13F +1,380 shares

    0.01% of the 13F portfolio, value $265,398.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 6,788 shares
    Change vs previous 13F +1,706 shares

    0.01% of the 13F portfolio, value $279,687.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 5,082 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $212,140.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).